| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 758854 | 40773 | VACUNA BCG 0,75 mg/ml POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE | VACUNA BCG 0,75 mg/ml POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE, 1 vial multidosis (10 dosis) + 1 vial de disolvente | N/A (vacuna) | 45 | 10 | 45 | 1 vial multidosis (10 dosis) + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/40773/40773_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/40773/40773_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23742 | MEDICARE PHARMA S.L. | 1965-04-01 | 1 | 1 | 1 | 1965-04-01 | 1965-04-01 | 1 | 2011-02-11 | 635748 | View Edit Delete | |||||||||||
| 759470 | 1191361004 | SKYRIZI 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | SKYRIZI 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 600 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191361004/1191361004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191361004/1191361004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2022-12-15 | 1 | 1 | 1 | 2022-12-16 | 2022-12-15 | 1 | 2023-08-12 | View Edit Delete | ||||||||||||
| 759296 | 1221664001 | CEVENFACTA 1 MG (45 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 1 MG (45 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 1 mg (45.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664001/1221664001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664001/1221664001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | LFB BIOTERAPIAS HISPANIA S.L. | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 759310 | 1221664002 | CEVENFACTA 2 MG (90 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 2 MG (90 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 2 mg (90.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664002/1221664002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664002/1221664002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | LFB BIOTERAPIAS HISPANIA S.L. | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 759311 | 1221664003 | CEVENFACTA 5 MG (225 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 5 MG (225 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 5 mg (225.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664003/1221664003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664003/1221664003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | LFB BIOTERAPIAS HISPANIA S.L. | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 759247 | 1221691001 | XIMLUCI 10 MG/ML SOLUCION INYECTABLE | XIMLUCI 10 MG/ML SOLUCION INYECTABLE, 1 vial de 0,23 ml + 1 aguja con filtro | 10 mg/ml inyectable 0,23 ml | 45 | 1 | 34 | 1 vial de 0,23 ml + 1 aguja con filtro | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221691001/1221691001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221691001/1221691001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2787 | LABORATORIO STADA S.L. | 2022-11-22 | 1 | 1 | 1 | 2022-11-23 | 2022-11-22 | 1 | 2023-04-14 | View Edit Delete | ||||||||||||
| 759433 | 1221630001 | KIMMTRAK 100 MICROGRAMOS/0,5 ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KIMMTRAK 100 MICROGRAMOS/0,5 ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 0,5 ml | 100 microgramos inyectable 0,5 ml | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221630001/1221630001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221630001/1221630001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 41387 | EUROMED PHARMA SPAIN S.L. | 2022-12-09 | 1 | 1 | 1 | 2022-12-10 | 2022-12-09 | 1 | 2024-02-14 | View Edit Delete | ||||||||||||
| 757976 | 87951 | LETYBO 50 UNIDADES POLVO PARA SOLUCION INYECTABLE | LETYBO 50 UNIDADES POLVO PARA SOLUCION INYECTABLE, 1 vial | 50 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87951/87951_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87951/87951_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12500 | CROMA-PHARMA GMBH | 2022-07-06 | 1 | 1 | 1 | 2022-07-07 | 2022-07-06 | 1 | 2022-11-21 | View Edit Delete | ||||||||||||
| 758340 | 1221683001 | VABYSMO 120 MG/ML SOLUCION INYECTABLE | VABYSMO 120 MG/ML SOLUCION INYECTABLE, 1 vial de 0,24 ml | 120 mg/ml inyectable 0,24 ml | 45 | 1 | 34 | 1 vial de 0,24 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221683001/1221683001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221683001/1221683001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2022-09-29 | 1 | 1 | 1 | 2022-09-30 | 2022-09-29 | 1 | 2023-08-03 | View Edit Delete | ||||||||||||
| 758197 | 1221674001 | VYVGART 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN | VYVGART 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial de 20 ml | 20 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221674001/1221674001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221674001/1221674001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 41147 | ARGENX SPAIN S.L. | 2022-09-29 | 1 | 1 | 1 | 2022-09-30 | 2022-09-29 | 1 | 2023-11-13 | View Edit Delete | ||||||||||||
| 758336 | 1221673001 | RANIVISIO 10 MG/ML SOLUCION INYECTABLE | RANIVISIO 10 MG/ML SOLUCION INYECTABLE, 1 vial de 0,23 ml | 10 mg/inyectable 0,23 ml | 45 | 1 | 34 | 1 vial de 0,23 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221673001/1221673001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221673001/1221673001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10611 | TEVA PHARMA S.L.U. | 2022-09-29 | 1 | 1 | 1 | 2022-09-30 | 2022-09-29 | 1 | 2023-03-14 | View Edit Delete | ||||||||||||
| 761416 | 1221688001 | SPEVIGO 450 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | SPEVIGO 450 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales de 7,5 ml | 450 mg inyectable 7,5 ml | 45 | 2 | 34 | 2 viales de 7,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221688001/1221688001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221688001/1221688001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8764 | LABORATORIOS LEO PHARMA S.A. | 2023-01-13 | 1 | 1 | 1 | 2023-01-14 | 2023-01-13 | 1 | 2024-03-11 | View Edit Delete | ||||||||||||
| 758062 | 1211602001 | UPLIZNA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | UPLIZNA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 3 viales de 10 ml | 100 mg inyectable 10 ml | 45 | 3 | 34 | 3 viales de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211602001/1211602001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211602001/1211602001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | AMGEN S.A. | 2022-07-22 | 1 | 1 | 1 | 2022-07-23 | 2022-07-22 | 1 | 2023-02-09 | View Edit Delete | ||||||||||||
| 758181 | 1221675001 | TECVAYLI 10 MG/ML SOLUCION INYECTABLE | TECVAYLI 10 MG/ML SOLUCION INYECTABLE, 1 vial de 3 ml | 10 mg/ml inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221675001/1221675001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221675001/1221675001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2022-09-07 | 1 | 1 | 1 | 2022-09-08 | 2022-09-07 | 1 | 2024-04-08 | View Edit Delete | ||||||||||||
| 758182 | 1221675002 | TECVAYLI 90 MG/ML SOLUCION INYECTABLE | TECVAYLI 90 MG/ML SOLUCION INYECTABLE, 1 vial de 1,7 ml | 90 mg/ml inyectable 1,7 ml | 45 | 1 | 34 | 1 vial de 1,7 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221675002/1221675002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221675002/1221675002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2022-09-07 | 1 | 1 | 1 | 2022-09-08 | 2022-09-07 | 1 | 2024-04-08 | View Edit Delete | ||||||||||||
| 758486 | 1221667001 | VEGZELMA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | VEGZELMA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 25 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221667001/1221667001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221667001/1221667001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | CELLTRION FARMACÉUTICA (ESPAÑA) S.L. | 2022-10-05 | 1 | 1 | 1 | 2022-10-06 | 2022-10-05 | 1 | 2022-12-13 | View Edit Delete | ||||||||||||
| 758487 | 1221667001 | VEGZELMA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | VEGZELMA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 ml | 25 mg/ml inyectable 16 ml | 45 | 1 | 34 | 1 vial de 16 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221667001/1221667001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221667001/1221667001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | CELLTRION FARMACÉUTICA (ESPAÑA) S.L. | 2022-10-05 | 1 | 1 | 1 | 2022-10-06 | 2022-10-05 | 1 | 2022-12-13 | View Edit Delete | ||||||||||||
| 758311 | 171214001IP | BAVENCIO 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | BAVENCIO 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial 10 ml | 20 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/171214001IP/171214001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/171214001IP/171214001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29251 | ABACUS MEDICINE A/S | 2022-09-16 | 1 | 1 | 1 | 2022-09-17 | 2022-09-16 | 1 | 2023-01-30 | View Edit Delete | ||||||||||||
| 758029 | 1211586001 | VORAXAZE 1.000 UNIDADES POLVO PARA SOLUCION INYECTABLE | VORAXAZE 1.000 UNIDADES POLVO PARA SOLUCION INYECTABLE, 1 vial | 1.000 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211586001/1211586001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211586001/1211586001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 71545 | SERB | 2022-08-04 | 1 | 1 | 1 | 2022-08-05 | 2022-08-04 | 1 | 2023-10-01 | View Edit Delete | ||||||||||||
| 758301 | 88087 | IG VENA 50 G/L SOLUCION PARA PERFUSION | IG VENA 50 G/L SOLUCION PARA PERFUSION, 1 vial de 200 ml | 10 g inyectable perfusión 200 ml | 45 | 1 | 34 | 1 vial de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88087/88087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88087/88087_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 88087 | KEDRION S.P.A. | 2023-01-27 | 1 | 1 | 1 | 2023-01-27 | 2023-01-27 | 0 | 2025-12-22 | View Edit Delete |
Page 67 of 1036, showing 20 records out of 20716 total, starting on record 1321, ending on 1340